StockData
Elevance Health, Inc. logo

Elevance Health, Inc. (ELV) operating KPIs

ELVNYSEHospital & Medical Service PlansFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Oct 21, 2026Score 15/3012% below fair value
$420.07−1.95 (-0.46%)

Close on Oct 30, 2026Market cap $91.10BP/E 18.7Yield –

Elevance Health carelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M)

Quarterly figures from Elevance Health's filings and investor materials

QuarterlyAnnual
Latest, Q3 2026
10,779
Period ended Sep 30, 2026
Change on a year earlier
+5.6%
10,209 in Q3 2025
History
11 quarters
Since Q1 2024
Sources
8
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M)Year on yearSource
Q3 2026Sep 30, 202610,779+5.6%10-Q (2026-10-21) ↗
Q2 2026Jun 30, 202610,473+6.0%10-Q (2026-07-15) ↗
Q1 2026Mar 31, 20269,830+5.9%10-Q (2026-04-22) ↗
Q4 2025Dec 31, 202510,700+15.9%Tách kỳ Q4 = FY2025 (10-K (FY2025, 2026-02-06)) − 9M2025 (10-Q (2026-10-21)) ↗
Q3 2025Sep 30, 202510,209+22.5%10-Q (2026-10-21) ↗
Q2 2025Jun 30, 20259,884+22.9%10-Q (2026-07-15) ↗
Q1 2025Mar 31, 20259,284+25.9%10-Q (2026-04-22) ↗
Q4 2024Dec 31, 20249,229–Tách kỳ Q4 = FY2024 (10-K (FY2025, 2026-02-06)) − 9M2024 (10-Q (2025-10-21)) ↗
Q3 2024Sep 30, 20248,336–10-Q (2025-10-21) ↗
Q2 2024Jun 30, 20248,040–10-Q (2025-07-17) ↗
Q1 2024Mar 31, 20247,373–10-Q (2025-04-22) ↗

Cite this data

StockData. (2026). Elevance Health CarelonRx — Cost of Products Sold (incl. Intersegment, ASU 2023-07) ($M), quarterly Q1 2024–Q3 2026 [Data set]. Compiled from Elevance Health SEC filings and investor materials. https://stockdatahq.com/stocks/elv/kpis/seg_carelonrx_cost_of_products

See every metric in the Elevance Health KPI table. Data updated Oct 28, 2026.